Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation
about
A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllersNew flow cytometric assays for monitoring cell-mediated cytotoxicityEffect of helixor A on natural killer cell activity in endometriosisInnate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.Reduced degranulation of NK cells in patients with frequently recurring herpes.Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug usersIntermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8+CD38+ in chronic fatigue syndrome/myalgic encephalomyelitis.Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).Termination of the Activating NK Cell Immunological Synapse Is an Active and Regulated Process.
P2860
Q33982102-26841CAC-2599-466E-BDA1-762D312567B6Q34027777-98E49B27-792C-47BB-BB71-61AE965C9A3DQ34784743-99478786-FB36-4AE2-9EBD-2F4BFB4DB6F0Q35085106-AC378356-CC0F-4A35-A25D-95C2837562D7Q35191244-26A37BE7-0839-410E-82C9-CBC93913231FQ35660526-3E196C32-D00D-4D41-9A2D-C93C1D316A69Q37699630-26471D5E-674B-497C-8C20-67BB8DB57A20Q37854081-FF75AD1C-6ACA-4F48-98F8-C780BCF45D68Q40073065-3D3730DD-0892-4B08-8458-DFF9517B811E
P2860
Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Retention of viability, cytoto ...... lls after CD107a degranulation
@en
Retention of viability, cytoto ...... ls after CD107a degranulation.
@nl
type
label
Retention of viability, cytoto ...... lls after CD107a degranulation
@en
Retention of viability, cytoto ...... ls after CD107a degranulation.
@nl
prefLabel
Retention of viability, cytoto ...... lls after CD107a degranulation
@en
Retention of viability, cytoto ...... ls after CD107a degranulation.
@nl
P2093
P2860
P356
P1476
Retention of viability, cytoto ...... lls after CD107a degranulation
@en
P2093
Costin Tomescu
Jihed Chehimi
Luis J Montaner
Vernon C Maino
P2860
P304
P356
10.1189/JLB.1008635
P577
2009-02-23T00:00:00Z